Cancer BiologybioRxiv
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
J. Hall, Z. Zhang, D. Wang…·M. Kortylewski
This paper develops a PROTAC-based strategy to selectively degrade activated STAT3 in specific cell types, showing efficacy in reducing STAT3 levels and tumor growth in lymphoma models.